Table 4.
Changes in Additional SF-36 Scales From Pre- to Day 7 Post-first vaccinationa (Total Vaccinated Cohort)
Role Physical | Bodily Pain | General Health | Vitality | Social Functioning | Role Emotional | Mental Health | |
---|---|---|---|---|---|---|---|
Day −7 | 84.2 | 75.1 | 77.6 | 70.2 | 91.7 | 90.8 | 83.6 |
Day 0a | 87.8 | 78.1 | 77.8 | 73.7 | 93.3 | 92.7 | 85.8 |
Pre-vaccination | 86.0 | 76.5 | 77.7 | 71.9 | 92.3 | 91.8 | 84.7 |
Post-first vaccination | 87.5 | 77.2 | 77.4 | 73.8 | 92.2 | 93.3 | 87.2 |
Change from pre- to post- first vaccination | 1.4 | 0.8 | −0.1 | 1.8 | −0.9 | 0.8 | 1.9 |
SE of mean change | 0.89 | 1.00 | 0.52 | 0.65 | 0.82 | 0.71 | 0.49 |
Notes: Pre-vaccination is calculated as mean of Day −7 and Day 0 assessments; post-first-vaccination score measured on Day 7; high score represents high level of functioning/quality of life. Change from pre-vaccination is the change from derived pre- to post-first-vaccination scores.
aRecombinant zoster vaccine Dose 1 administered on Day 0.